Media center

At PATH, our global health experts are developing partnerships, new devices, and solutions to the world's most pressing health needs. Contact us to speak with one of PATH's experts today.

Contact Us

Director of Global Strategic Communications:
David Verga

Email: media@path.org

Recent Press Coverage

  1. Dr. Cathy Ndiaye, Director of HPV Vaccine Programs at PATH, shares her personal connection to the fight against cervical cancer and her efforts to address disparities in prevention and care.
    Published: November 2024
  2. Nikolaj Gilbert, President and CEO of PATH, shares insights on the growing trend of global health organizations appointing Chief AI Officers (CAIOs) to harness the transformative potential of artificial intelligence in healthcare.
    Published: September 2024
  3. The first vaccine for malaria received major regulatory approval in 2015. It didn’t become part of vaccination programs in Africa until 2024. PATH's Ashley Birkett speaks about the manufacturing plans that GSK had put in place were derailed.
    Published: July 2024
  4. Neeraj Jain, PATH’s Country Director for India, speaks on the role of technology in revolutionizing health care, improving outcomes, and driving medical research in India.
    Published: June 2024

We develop evidence-based expertise and resources

Our global team leverages data and evidence to develop resources and innovations that bring good health to more people.

Explore our evidence

Join the latest discussions on health equity.

We partner with the public and private sector, government, and academia from around the world to share insightful conversations on the latest topics affecting health equity.

Explore PATH events

PATH Newsroom

Related articles

Read our latest

971 Item s
971 Item s
    Date
    From
    To
  1. Over 80% of the 139,021 malaria cases reported in Brazil in 2021 were caused by P. vivax.Handheld test and single-dose medicine will support Brazil’s malaria elimination goal by improving patient adherence and ensuring patient safety.
    Published: June 2023
    Press Release
  2. The partnership seeks to leverage expertise in vaccine development, digital health systems, and biobanking to advance global health equity and foster innovative solutions in Saudi Arabia and beyond.
    Published: June 2023
    Press Release
  3. Resolution urges action to sustain gains and drive progress toward reliable and sustained oxygen access for all
    Published: May 2023
    Press Release
  4. Results from a Phase 3 clinical study of a pentavalent meningococcal meningitis vaccine candidate designed for use in the African meningitis belt demonstrate it to be safe, well tolerated, and capable of producing strong immune responses to all five serogroups.
    Published: May 2023
    Announcement
  5. Published: May 2023
    Announcement